Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Regeneron's Libtayo posts lung cancer win with Bristol's Yervoy. But company won't seek approval
Fierce Pharma
Thu, 12/1/22 - 07:11 pm
Tags:
Regeneron, Libtayo, non-small cell lung cancer, Bristol Myers Squibb, Yervoy
UK regulators warn of ocular side effects after treatment with Sanofi's Dupixent
Fierce Pharma
Thu, 12/1/22 - 10:43 am
Tags:
Regeneron, Sanofi, Dupixent, UK, side effects
Regeneron, CytomX Ink Potentially $2B Bispecific Immunotherapy Deal
BioSpace
Thu, 11/17/22 - 12:05 pm
Tags:
Regeneron, CytomX Therapeutics, bispecifics, cancer, Veloci-Bi, drug development
AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions
Fierce Pharma
Mon, 11/14/22 - 07:10 pm
Tags:
Europe, AstraZeneca, Sanofi, COVID-19, cancer, GSK, Regeneron
Dupixent nears EU approval for rare skin disease prurigo nodularis
Pharmaphorum
Mon, 11/14/22 - 10:52 am
Tags:
Sanofi, Regeneron, Dupixent, Europe, prurigo nodularis
Catching up with Keytruda, Regeneron scores frontline NSCLC approval for Libtayo/chemo combo
Endpoints
Wed, 11/9/22 - 10:38 am
Tags:
Regeneron, Libtayo, non-small cell lung cancer, Keytruda, Merck
Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron
Fierce Pharma
Mon, 11/7/22 - 10:55 am
Tags:
Amgen, Repatha, patents, Supreme Court, Sanofi, Regeneron
Insmed, Alnylam and others make Science's list of top 20 biopharma employers
Endpoints
Sun, 11/6/22 - 01:32 pm
Tags:
employers, Inbsmed, Alnylam, Regeneron, Incyte
Regeneron scratches NGF inhibitor and cat allergy therapy from pipeline
Fierce Biotech
Thu, 11/3/22 - 11:53 am
Tags:
Regeneron, chronic pain, cat allergy
Regeneron, Bayer's Eylea nabs six months of pediatric exclusivity as competition waits to enter the market
Endpoints
Mon, 10/24/22 - 11:10 pm
Tags:
Regeneron, Bayer, Eylea, pediatric exclusivity, biosimilars
Sanofi, Regeneron team with Broadway actor for digital severe asthma program
Medical Marketing and Media
Wed, 10/19/22 - 10:54 pm
Tags:
asthma, severe asthma, Sanofi, Regeneron, pharma marketing
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
Fri, 10/14/22 - 10:38 am
Tags:
FDA, Phanes, Pfizer, GSK, Regeneron, Eagle Pharmaceuticals, Galactin Therapeutics, BridgeBio, Gilead Sciences, Covis Pharma, scPharmaceuticals, XACT Robotics, BioMind Labs
Regeneron secures priority review for Eylea's use in infant retinopathy
Fierce Pharma
Wed, 10/12/22 - 11:40 pm
Tags:
Eylea, Regeneron, retinopathy of prematurity, FDA, priority review
Dupixent Shows Promise as First Treatment for Childhood EoE
BioSpace
Wed, 10/12/22 - 10:33 am
Tags:
Dupixent, Sanofi, Regeneron, pediatric, clinical trials, eosinophilic esophagitis
The gloom deepens for biopharma stocks
EP Vantage
Mon, 10/10/22 - 06:54 pm
Tags:
biopharma stocks, AbbVie, Alnylam, AstraZeneca, Biogen, CRISPR Therapeutics, Daiichi Sankyo, Eisai, Eli Lilly, GSK, Intellia Therapeutics, Regeneron, Roche, Sanofi, Sarepta Therapeutics
FDA approves Sanofi and Regeneron’s Dupixent to treat prurigo nodularis
Pharmaceutical Business Review
Thu, 09/29/22 - 10:05 am
Tags:
Sanofi, Regeneron, Dupixent, prurigo nodularis, FDA
Biden admin says Supreme Court should reject Amgen's petition to take up Repatha patent case
Fierce Pharma
Thu, 09/22/22 - 11:14 pm
Tags:
Amgen, patents, Supreme Court, Repatha, Sanofi, Regeneron
Intellia's gene editing therapies both post early successes as evidence grows for CRISPR potential
Fierce Biotech
Fri, 09/16/22 - 10:53 am
Tags:
Intellia Therapeutics, gene editing, NTLA-2001, ATTR amyloidosis, clinical trials, Regeneron
ESMO 2022 movers – KRAS backfires
EP Vantage
Thu, 09/15/22 - 10:12 am
Tags:
ESMO, KRAS inhibitors, Relay Therapeutics, Regeneron, Amgen, Deciphera, Clovis Oncology, Ayala Pharmaceuticals, Springworks, Mirati Therapeutics
Regeneron Highlights Plug-and-Play Oncology Strategy at ESMO
BioSpace
Mon, 09/12/22 - 11:32 pm
Tags:
ESMO, Regeneron, Libtayo

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.